openPR Logo
Press release

Recombinant Human Endostatin Market 2018 Exclusively Available By Leading Key Players: Pfizer Inc., Novus Biologicals, Biocon, Thermo Fisher Scientific, Yantai Medgenn Ltd

05-29-2019 11:28 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Recombinant Human Endostatin

Recombinant Human Endostatin

Increasing research and development activities for identifying potential uses of recombinant human endostatin is expected to propel growth of the market. For instance, according to a paper published in the journal Nature, September 2015, a study was conducted to evaluate effects of recombinant human endostatin in combination with radiotherapy for treating esophageal squamous cell carcinoma and to discover its potential mechanisms. These findings suggested that recombinant human endostatin is a potential anti-angiogenic agent in esophageal squamous cell carcinoma mainly when combined with radiotherapy.

Request Sample Report @ www.coherentmarketinsights.com/insight/request-sample/2262

Furthermore, according to National Center for Biotechnology Information (NCBI) January 2017, recombinant human endostatin in combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) may aid in treatment of Angioimmunoblastic T Cell Lymphoma (AITL), a form of Peripheral T Cell Lymphoma (PTCL). Such novel therapies for PTCL treatment are immediately desired to improve the outcomes of patients with this disease. These factors are expected to propel growth of the recombinant human endostatin market.

Endostatin is a protein located in most Basement Membranes (BMs) in the body such as vascular basement membranes. A number of clinical studies have validated the significant survival benefits of recombinant human endostatin in treating late stage Non-Small-Cell Lung Carcinoma (NSCLC). Therefore, recombinant human endostatin (Endostar) was approved by the State Food and Drug Administration of China (CFDA) in September 2005, for the treatment of NSCLC. Endostatin is expressed in various organs, with the highest levels in liver, lung, and kidney.

Government initiatives to reduce prices of anticancer drugs is expected to drive growth of the recombinant human endostatin market during the forecast period. For instance, in August 2018, Government of China took initiatives to reduce prices of anticancer drugs by 44%. Chinese National Health and Family Planning Commission organized a national-wide drug price and reimbursement drug list negotiation, in which a total of 39 products have been successfully added including recombinant human endostatin.

Request Customization Report@ https://www.coherentmarketinsights.com/insight/request-customization/2262

Increasing challenges in significant production of recombinant human endostatin is expected to hinder the market growth. For instance, in April 2017, according to a National Center for Biotechnology Information (NCBI) report, tumor treatment needs large quantities of biologically active recombinant human endostatin, which in turn requires production of large quantities of recombinant human endostatin. This process is difficult as it based on recombinant DNA technology and also have low success rates for the treatment of cancer. Furthermore, the cost of recombinant human endostatin is high and it has short half-life. Endostatin is unstable since, endostatin-purification process may denature its structure and the resultant yields may be low.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recombinant Human Endostatin Market 2018 Exclusively Available By Leading Key Players: Pfizer Inc., Novus Biologicals, Biocon, Thermo Fisher Scientific, Yantai Medgenn Ltd here

News-ID: 1757391 • Views:

More Releases from Coherent Market Insights

Meal Replacement Market Market to Hit $22.01 Bn by 2032 with a CAGR of 5.8% |Abbott Laboratories, Amway, Atkins, Blue Diamond Growers
Meal Replacement Market Market to Hit $22.01 Bn by 2032 with a CAGR of 5.8% |Abb …
The Meal Replacement Market is estimated to be valued at USD 14.82 Bn in 2025 and is expected to reach USD 22.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Meal Replacement Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth
Deep Cycle Battery Market, Market Outlook : Projected to Exceed USD 4.73 Billion by 2032 with a 7.9% CAGR |C&D Technologies Inc., Crown Battery Manufacturing Co., East Penn Manufacturing Co. Inc., EnerSys
Deep Cycle Battery Market, Market Outlook : Projected to Exceed USD 4.73 Billion …
The deep cycle battery market is estimated to be valued at USD 2.77 billion in 2025 and is expected to reach USD 4.73 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Deep Cycle Battery Market, Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business
Consumer Electronics Packaging Market Market Projected to Witness Huge Growth by 2025-2032 |Hangzhou Xunda Packaging Co., Smurfit Kappa Group PLC, DS Smith Plc, Pregis Corporation
Consumer Electronics Packaging Market Market Projected to Witness Huge Growth by …
The consumer electronics packaging market is estimated to be valued at USD 26.57 Bn in 2025 and is expected to reach USD 81.72 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.4% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Consumer Electronics Packaging Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,
Ceramic Armor Market Market Set to Witness Significant Growth by 2025-2032 |Koninklijke DSM N.V., BAE Systems, Morgan Advanced Materials , Saint-Gobain S.A.
Ceramic Armor Market Market Set to Witness Significant Growth by 2025-2032 |Koni …
The global ceramic armor market is estimated to be valued at USD 2.75 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Ceramic Armor Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,

All 5 Releases


More Releases for Endostatin

Recombinant Human Endostatin Market Size, Share and Trends Analysis Report 2024- …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Recombinant Human Endostatin Market - (By Type (purity 95% and others) And By Application (medical care, scientific research and others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Recombinant Human Endostatin Market is valued at US$ 133.3 Mn in 2023, and it is expected to
[Expert View] Recombinant Human Endostatin Market Innovating Cancer Therapeutics …
"Empowering Businesses with Innovative Market Solutions for Smarter Decision-Making" Recombinant Human Endostatin Market Size is valued at USD 135.2 Million in 2024 and is predicted to reach USD 248.5 Millionby the year 2032 at an 8.5% CAGR during the forecast period for 2024-2032. The Recombinant Human Endostatin Market Size, Scope, and Forecast 2024-2033 report has been added to the Market research collection of Exactitude Consultancy reports. The recombinant human endostatin market is
Recombinant Human Endostatin Market Segmentation, Trends, and Growth Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Recombinant Human Endostatin Market - (By Type (purity 95% and others) And By Application (medical care, scientific research and others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Recombinant Human Endostatin Market is valued at US$ 133.3 Mn in 2023, and it is expected to
Recombinant Human Endostatin Market Qualitative Analysis, Product Scope, Overvie …
"In the current competitive market space, industry analysis is a crucial step that aids in the identification of the appropriate target customers and subsequently provides tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behaviour, existing and upcoming business models, and technological
Global Recombinant Human Endostatin Market Forecast 2019-2026 Thermo Fisher Scie …
Market study on Global Recombinant Human Endostatin 2019 Research Report presents a professional and complete analysis of Global Recombinant Human Endostatin Market on the current market situation. Report provides a general overview of the Recombinant Human Endostatin industry 2019 including definitions, classifications, Recombinant Human Endostatin market analysis, a wide range of applications and Recombinant Human Endostatin industry chain structure. The 2019's report on Recombinant Human Endostatin industry offers the global
Global Recombinant Human Endostatin Market Research Report 2017 Analysis and For …
Executive Summary:- Global Recombinant Human Endostatin Market: WiseGuyReports.com adds “Recombinant Human Endostatin Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database. WiseGuyReports.Com Publish a New Market Research Report On – Request a Sample Report @ https://www.wiseguyreports.com/sample-request/972670-global-recombinant-human-endostatin-market-research-report-2017 Notes: Production, means the output of Recombinant Human Endostatin Revenue, means the sales value of Recombinant Human Endostatin This report studies Recombinant Human Endostatin in Global market, especially in North America, Europe, China, Japan, Southeast